Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Kleanthous

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
NPJ Vaccines|May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in miceLilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Science Translational Medicine|May 10, 2023
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccineYupeng Feng, Meng Yuan, John M Powers, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.
Vaccine|September 9, 2019
Comparison of adjuvants to optimize influenza neutralizing antibody responsesRebecca S Rudicell, Marie Garinot, Masaru Kanekiyo, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
NPJ Vaccines|May 23, 2022
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in miceLilit Grigoryan, Audrey Lee, Alexandra C Walls, et al.
Science Translational Medicine|May 10, 2023
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccineYupeng Feng, Meng Yuan, John M Powers, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 6